TY - JOUR
T1 - State of the Evidence for Use of Psychotropic Medications in School-Age Youth
AU - Shahidullah, Jeffrey D.
AU - Roberts, Holly
AU - Parkhurst, John
AU - Ballard, Rachel
AU - Mautone, Jennifer A.
AU - Carlson, John S.
N1 - Publisher Copyright:
© 2023 by the authors.
PY - 2023/9
Y1 - 2023/9
N2 - Psychotropic medications are commonly prescribed to school-aged youth for the management of mental health concerns. This paper describes the current state of evidence for psychotropic medications in school-aged youth. More specifically, the following sections summarize relevant medication research trials and practice parameters pertaining to psychotropic medication prescribing as well as the specific medications indicated for a range of commonly presenting disorders and symptom clusters in school-aged youth. For each of these disorders and symptom clusters, key findings pertaining to the current state of science and practice are highlighted for the purpose of offering patients, clinicians, researchers, and policymakers with nuanced considerations for the role of psychopharmacology within the context of a larger “whole-child” approach to care that relies on the collaboration of providers and services across systems of care to promote optimal child and family health and wellness. The paper concludes with a discussion about supporting the use of medication treatments in schools, including considerations for ensuring effective family-school-health system collaboration to best meet youth mental health needs.
AB - Psychotropic medications are commonly prescribed to school-aged youth for the management of mental health concerns. This paper describes the current state of evidence for psychotropic medications in school-aged youth. More specifically, the following sections summarize relevant medication research trials and practice parameters pertaining to psychotropic medication prescribing as well as the specific medications indicated for a range of commonly presenting disorders and symptom clusters in school-aged youth. For each of these disorders and symptom clusters, key findings pertaining to the current state of science and practice are highlighted for the purpose of offering patients, clinicians, researchers, and policymakers with nuanced considerations for the role of psychopharmacology within the context of a larger “whole-child” approach to care that relies on the collaboration of providers and services across systems of care to promote optimal child and family health and wellness. The paper concludes with a discussion about supporting the use of medication treatments in schools, including considerations for ensuring effective family-school-health system collaboration to best meet youth mental health needs.
KW - mental health
KW - pediatric psychopharmacology
KW - psychotropic medications
KW - school age youth
UR - http://www.scopus.com/inward/record.url?scp=85172096240&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=85172096240&partnerID=8YFLogxK
U2 - 10.3390/children10091454
DO - 10.3390/children10091454
M3 - Review article
C2 - 37761415
AN - SCOPUS:85172096240
SN - 2227-9067
VL - 10
JO - Children
JF - Children
IS - 9
M1 - 1454
ER -